MFN Partners Management, LP In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 12, 2025), MFN Partners Management, LP reported 10 stock positions worth $4.9 billion . Its top holding was Xpo (XPO) at 30.5% of the portfolio, followed by Qxo (QXO, 15.2% ) and Rxo (RXO, 13.4% ). Compared with Q3 2024, it sold out of 1 and reduced 1. The biggest sale was Qxo (QXO, shares −13% ).
Location BOSTON, MA
CIK 0001732811
Portfolio Value $4.9B (Q4 2024) Holdings 10 stocks · $4.9B Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2024 XPO Xpo Inc. 30.45% 11,425,369 $1.5B No change QXO Qxo Inc. 15.16% 46,908,701 $745.8M Reduce -13.0% RXO Rxo Inc. 13.36% 27,577,666 $657.5M No change TLN Talen Energy Corp. 12.28% 3,000,000 $604.4M No change CNX CNX Resources Corp. 11.18% 15,000,000 $550.0M No change PFSI Pennymac Financial Services 9.41% 4,531,792 $462.9M No change HCA HCA Healthcare Inc. 5.94% 973,898 $292.3M No change BHC Bausch Health Cos Inc. 0.98% 6,000,000 $48.4M No change FWRD Forward Air Corp. 0.85% 1,289,358 $41.6M No change IE Ivanhoe Electric Inc. / US 0.39% 2,553,191 $19.3M No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $156.8M (not counted above) Security Class Shares / Principal Value Change OXY.WS Occidental Petroleum-CW27 *W EXP 08/03/202 5,690,600 $156.8M No change
Total filed on the 13F, all lines: $5.1B.
Portfolio Sells Q3 2024 → Q4 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▲ QXO Qxo Inc. Reduce -13.0% 15.16% −2.18 CYCLERION THERAPEUTICS INC Sold out 0.00% −0.01
Portfolio Buys Q3 2024 → Q4 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▼ None this quarter.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 8 $4.8B XPO, TLN, RXO, QXO, PFSI Q1 2026 8 $4.5B XPO, TLN, QXO, RXO, PFSI Q4 2025 Amended 9 $4.6B XPO, TLN, PFSI, QXO, RXO Q3 2025 8 $4.8B XPO, TLN, QXO, PFSI, RXO Q2 2025 8 $4.6B XPO, QXO, TLN, PFSI, RXO Q1 2025 9 $4.1B XPO, QXO, TLN, RXO, PFSI Q4 2024 10 $4.9B XPO, QXO, RXO, TLN, CNX Q3 2024 11 $4.9B XPO, QXO, RXO, TLN, PFSI Q2 2024 9 $2.7B XPO, RXO, PFSI, HCA, LAD Q1 2024 9 $3.3B XPO, LAD, PFSI, RXO, HCA